Date: 2012-11-01
Type of information: R&D agreement
Compound: control markers for stem cell production
Company: EMD Millipore, the Life Science division of Merck KGaA (Germany) Sistemic (UK)
Therapeutic area: Technology - Services
Type agreement: R&D
Action mechanism:
Disease:
Details: EMD Millipore, the Life Science division of Merck KGaA, has announced a new initiative with Sistemic Ltd., a leading provider of microRNA-based problem-solving services and kit-based products. The two companies are jointly developing a proprietary monitoring methodology utilizing Sistemic\'s microRNA marker detection capability to enable consistent growth of stem cells in EMD Millipore\'s Mobius® CellReady platform. These markers could also be incorporated into a commercially-available kit for quality control of stem cells in culture.
Financial terms:
Latest news:
